XML 40 R30.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2021
Summary of Assumptions Used in Black-Scholes Option Pricing Model The fair values of stock options granted during the three months ended March 31, 2021 and 2020 were estimated as of the dates of grant using the Black-Scholes option pricing model with the following assumptions:

Three Months Ended

March 31, 

    

2021

    

2020

    

Risk-free interest rate

 

0.66% - 1.21%

0.54% - 1.57%

 

Expected volatility

 

71.62% - 71.84%

73.72% - 74.71%

 

Expected dividend yield

 

0%

0%

 

Expected life of employee and Board options (in years)

 

6.25

6.25

 

Summary of Compensation Expense Relating to Stock Options

During the three months ended March 31, 2021 and 2020, the Company recognized compensation expense relating to stock options as follows:

Three Months Ended

March 31, 

    

2021

    

2020

    

Research and development

$

1,590

$

1,609

General and administrative

 

1,014

 

1,070

Total stock option expense

$

2,604

$

2,679

Summary of Stock Option Activity

A summary of stock option award activity related to employees, non-employee members of the Company’s Board of Directors and non-employee consultants as of and for the three months ended March 31, 2021 is presented below:

Weighted

Number of

Average Exercise

    

Shares

    

 Price

    

Outstanding, December 31, 2020

 

5,469,393

$

15.02

 

Granted

 

673,200

 

19.47

 

Exercised

 

(45,035)

 

15.29

 

Forfeited

 

(178,750)

 

17.30

 

Outstanding, March 31, 2021

 

5,918,808

$

15.46

Options exercisable, March 31, 2021

 

3,375,272

Employees And Non-Employee Members Of Board Of Directors [Member]  
Summary of Restricted Stock Unit Activity

A summary of restricted stock unit activity related to employees and non-employee members of the Company’s Board of Directors as of and for the three months ended March 31, 2021 is presented below:

Weighted

Number of

Average Grant

    

Units

    

Date Fair Value

Outstanding, December 31, 2020

 

235,250

$

16.25

Awarded

 

276,000

 

20.59

Vested and released

 

(109,419)

 

16.36

Outstanding, March 31, 2021

 

401,831

$

19.20

Restricted stock units exercisable (vested and deferred), March 31, 2021